Journal of Inflammation Research, 2024 · DOI: https://doi.org/10.2147/JIR.S491055 · Published: November 6, 2024
This study investigated the link between the systemic immune-inflammation index (SII) and deep vein thrombosis (DVT) in patients with spinal cord injury (SCI). We found that 23.1% of SCI patients had DVT. The risk of DVT was significantly increased by 39% with each 1-point increase in SII (OR = 1.39, 95% CI: 1.03–1.87, p = 0.031). Our results showed that higher SII values were associated with an increased risk of DVT, independent of other factors. This suggests that SII may be used as a potential biomarker to predict DVT in SCI patients, highlighting the importance of early detection and intervention.
SII can be used as a predictive biomarker for DVT risk in SCI patients.
The study highlights the importance of early detection and intervention strategies for DVT in SCI patients.
Clinicians should consider aberrant SII levels when managing DVT risk in SCI patients.